info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

US Chiral Chemicals Market Research Report: By Technology (Traditional Separation Method, Asymmetric Preparation Method, Biological Separation Method) and By Application (Pharmaceutical, Agrochemical, Flavors and Fragrances, Others) - Forecast to 2035


ID: MRFR/CnM/18871-US | 100 Pages | Author: MRFR Research Team| December 2023

US Chiral Chemicals Market Research Report: By Technology (Traditional Separation Method, Asymmetric Preparation Method, Biological Separation Method) and By Application (Pharmaceutical, Agrochemical, Flavors and Fragrances, Others) - Forecast to 2035.


US Chiral Chemicals Market Overview:


As per MRFR analysis, the US Chiral Chemicals Market Size was estimated at 14.23 (USD Billion) in 2023. The US Chiral Chemicals Market Industry is expected to grow from 18.5(USD Billion) in 2024 to 49.8 (USD Billion) by 2035. The US Chiral Chemicals Market CAGR (growth rate) is expected to be around 9.42% during the forecast period (2025 - 2035).


Key US Chiral Chemicals Market Trends Highlighted


The US Chiral Chemicals Market is currently experiencing several important trends shaped by various market drivers. One key market driver is the increasing demand for chiral materials in the pharmaceutical industry. The US is a global leader in pharmaceutical development and production, with a strong emphasis on developing and manufacturing enantiomerically pure drugs. This demand is driven by the growing awareness of the efficacy and safety of chiral drugs, as well as regulations that favor the use of chiral compounds in drug formulations. Opportunities are emerging in the form of advancements in chiral technology and continuous-flow synthesis processes, which could enhance efficiency and reduce costs in chiral chemical production.Companies are increasingly focusing on innovative methods to produce chiral compounds sustainably, aligning with environmental regulations and consumer preferences. This shift could allow businesses to capture a larger share of the market by minimizing waste and optimizing resource use. Recent trends also indicate a growing interest in chiral chemicals for applications beyond pharmaceuticals, such as agrochemicals and flavors and fragrances. This diversification is likely to bolster the market, reflecting the robust demand across various sectors. Additionally, the US government supports R&D initiatives to promote innovation in chiral synthesis, providing a conducive environment for growth in this sector.Overall, the combination of regulatory support, technological advancements, and diversification of applications positions the US Chiral Chemicals Market for continued growth and development in the coming years.

US Chiral Chemicals Market size

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


US Chiral Chemicals Market Drivers

Growing Pharmaceutical Demand


The US Chiral Chemicals Market Industry is significantly driven by the increasing demand for pharmaceuticals, particularly in the development of advanced therapeutics and personalized medicine. Reports suggest that around 70% of small-molecule drugs are produced using chiral chemicals, a trend attributed to their effectiveness and specificity in targeting diseases. The Pharmaceutical Research and Manufacturers of America (PhRMA) indicates a continuous rise in R&D expenditure aiming to innovate and develop new drugs, with 2022 seeing approximately $100 billion invested in drug development.This growing focus on personalized medicine, which emphasizes tailored treatments for individual patients, is also contributing to the demand for chiral chemicals. According to the US National Institutes of Health, personalized treatments can enhance patient outcomes by more than 30%, which in turn propels the sourcing of chiral chemicals in the industry.


Increased Regulatory Support


The regulatory landscape in the United States is increasingly supporting the use of chiral chemicals through favorable policies and frameworks designed to promote safer and more effective chemical processes. The US Food and Drug Administration (FDA) has established guidelines advocating the use of chiral compounds in drug formulations to minimize side effects while enhancing efficacy. According to FDA reports, around 50% of drug approvals in the last five years have involved chiral drugs, signaling a strong regulatory endorsement.This growing regulatory approval for chiral chemicals is likely to stimulate the US Chiral Chemicals Market Industry, allowing for a more extensive application of these compounds in various therapeutic areas.


Technological Advancements in Synthesis


Advancements in synthetic methodology and technology are crucial drivers of growth in the US Chiral Chemicals Market Industry. Innovations such as asymmetric synthesis and biocatalysis have revolutionized the production of chiral molecules, making processes more cost-effective and environmentally friendly. For example, the use of biocatalysts has increased by over 30% in chiral synthesis processes due to their efficiency and sustainability. The US Department of Energy has highlighted that such technological advancements not only enhance yield but also reduce the carbon footprint associated with chemical manufacturing, thereby bolstering the appeal and adoption of chiral chemicals in the US market.

US Chiral Chemicals Market Segment Insights:

Chiral Chemicals Market Technology Insights



The Technology segment within the US Chiral Chemicals Market showcases diverse methods that drive innovation and efficiency in producing chiral compounds. Traditional Separation Method remains a cornerstone for separating enantiomers, with its longstanding application in various industries, particularly within pharmaceuticals and agrochemicals. This method is characterized by its reliability and established protocols, making it a go-to approach for manufacturers looking to maintain quality and consistency in their products. However, the shifting landscape demands advancements, leading to increased interest in Asymmetric Preparation Method, which plays a vital role in developing chiral molecules more efficiently and selectively.This method not only reduces the waste associated with traditional processes but also enhances productivity, ensuring that manufacturers can meet the growing demand for chiral substances while adhering to environmental regulations. Additionally, Biological Separation Method is gaining traction, leveraging biocatalysis and enzyme-driven processes to achieve high selectivity and yields. This method is particularly significant due to its sustainability aspect, allowing manufacturers to minimize their ecological footprint while producing high-purity chiral chemicals.The ongoing research and development in these methods underscore the competitive dynamics of the US Chiral Chemicals Market, as companies strive to adopt innovative technologies that align with market demands. The rich landscape of technological advancements promises attractive opportunities for investment and growth, demonstrating how the Technology segment is poised to influence the broader market landscape significantly.


US Chiral Chemicals Market segment

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Chiral Chemicals Market Application Insights



The US Chiral Chemicals Market, particularly within the Application segment, plays a pivotal role in various industries, notably Pharmaceuticals, Agrochemicals, Flavors and Fragrances, and others. The Pharmaceutical sector demands chiral chemicals for drug formulation, ensuring efficacy and safety in treatments. With the growing focus on precision medicine, the need for chiral compounds is significant, driving research and development in this category. Agrochemicals utilize chiral chemicals to enhance agricultural product effectiveness, contributing to increased crop yields and sustainable farming practices.In the Flavors and Fragrances domain, chiral chemicals are essential for producing aromatic compounds that cater to consumer preferences, thus maintaining a competitive edge in a dynamic market. The Others category encompasses a range of applications, further highlighting the versatility and importance of chiral chemicals in modern manufacturing processes. Overall, the diverse applications showcase the critical nature of the US Chiral Chemicals Market, as it adapts to changing consumer demands and technological advancements, propelling growth in this sector.Market trends reveal a continued push towards sustainable and efficient production methods, optimizing the applications of chiral chemicals across industries.

US Chiral Chemicals Market Key Players and Competitive Insights:


The US Chiral Chemicals Market has been witnessing an increasing level of competition driven by advancements in technology, growing demand for chiral products, and applications across various sectors such as pharmaceuticals, agrochemicals, and nutraceuticals. The significance of chiral compounds stems from their unique properties, which are essential in drug formulation and synthesis due to their specific efficacy and reduced side effects. As a result, numerous players are exploring R&D collaborations, expanding their portfolios, and elevating their market strategies to capture a larger share of this lucrative segment. The market is characterized by established companies that are leveraging their technological advantages and extensive distribution networks, as well as emerging firms that are innovating to meet the evolving needs of customers.Chiral Technologies has established a strong presence in the US Chiral Chemicals Market, renowned for its expertise in chiral separation and analytical services. The company has made significant advancements in its technologies, providing effective solutions that cater to various industries including pharmaceuticals and biotechnology. Its strengths lie in its comprehensive range of products, which are tailored to meet the diverse needs of customers, and its commitment to high-quality service, which has reinforced customer loyalty. Chiral Technologies stands out with its robust support structure for clients, helping them navigate regulatory requirements and optimize their chiral separation processes. This focus on customer engagement and satisfaction has positioned Chiral Technologies as a formidable player in the market, enabling it to sustain growth in a competitive landscape.Tocris Bioscience has carved its niche within the US Chiral Chemicals Market by providing innovative solutions specifically designed for scientific research and drug development. The company's key products include a broad array of chiral compounds that facilitate research in areas such as neuroscience, cancer research, and immunology. Tocris Bioscience's strengths are reflected in its cutting-edge research and development capabilities, which allow it to continuously introduce new and unique compounds to the market. The company also benefits from an extensive distribution network that ensures rapid availability of its products to laboratories and researchers across the United States. In addition, Tocris Bioscience has engaged in various strategic partnerships and collaborations, enhancing its market presence and strengthening its innovation pipeline. Through these efforts, the company has not only expanded its product offerings but has also improved its competitive standing in the chiral chemicals domain.


Key Companies in the US Chiral Chemicals Market Include:

Chiral Technologies


Tocris Bioscience


Lonza Group


Merck


BASF


Asahi Kasei


Sigma Aldrich


Evonik Industries


Cambridge Isotope Laboratories


Sachem


Pfizer


Fisher Scientific


AbbVie


Aldrich Chemical


Wacker Chemie


US Chiral Chemicals Market Industry Developments


Recent developments in the US Chiral Chemicals Market have seen notable advancements, with companies such as Merck, BASF, and Sigma Aldrich focusing on expanding their product lines to enhance chiral separation technologies. In October 2023, Lonza Group announced a significant increase in its production capacity for chiral intermediates aimed at the pharmaceutical sector, reflecting the growing demand for precision pharmaceuticals. Additionally, in September 2023, AbbVie reported on its strategic collaborations with Chiral Technologies to develop innovative chiral molecules for new drug therapies, indicating a strong market interest in chiral compounds. Over the past two to three years, significant mergers in this sector include the acquisition of Tocris Bioscience by Merck in January 2022 which consolidated their chiral chemistry offerings, enhancing market competitiveness. Evonik Industries has also reported investments aimed at expanding its chiral synthesis capabilities. The market has experienced a valuation increase largely due to heightened demand for chiral drugs resulting from increased investment in Research and Development by major players, tapping into the robust biopharmaceutical industry in the US. These trends illustrate the dynamic growth and innovation within the US Chiral Chemicals Market.


US Chiral Chemicals Market Segmentation Insights

Chiral Chemicals Market Technology Outlook


Traditional Separation Method


Asymmetric Preparation Method


Biological Separation Method

Chiral Chemicals Market Application Outlook


Pharmaceutical


Agrochemical


Flavors and Fragrances


Others

Report Scope:
Report Attribute/Metric Source: Details
MARKET SIZE 2018 14.23(USD Billion)
MARKET SIZE 2024 18.5(USD Billion)
MARKET SIZE 2035 49.8(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 9.42% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
MARKET FORECAST PERIOD 2025 - 2035
HISTORICAL DATA 2019 - 2024
MARKET FORECAST UNITS USD Billion
KEY COMPANIES PROFILED Chiral Technologies, Tocris Bioscience, Lonza Group, Merck, BASF, Asahi Kasei, Sigma Aldrich, Evonik Industries, Cambridge Isotope Laboratories, Sachem, Pfizer, Fisher Scientific, AbbVie, Aldrich Chemical, Wacker Chemie
SEGMENTS COVERED Technology, Application
KEY MARKET OPPORTUNITIES Growing demand in pharmaceuticals, Increasing use in agrochemicals, Expansion of biotechnology applications, Rise in consumer goods requiring enantiomers, Advancements in chiral synthesis technologies
KEY MARKET DYNAMICS growing demand in pharmaceuticals, advancements in manufacturing technologies, increasing regulatory standards, rise of green chemistry, expansion of application areas
COUNTRIES COVERED US


Frequently Asked Questions (FAQ) :

The US Chiral Chemicals Market is expected to be valued at 18.5 USD Billion in 2024.

By 2035, the US Chiral Chemicals Market is projected to reach 49.8 USD Billion.

The US Chiral Chemicals Market is expected to have a CAGR of 9.42% from 2025 to 2035.

The Asymmetric Preparation Method holds the largest market share at 8.5 USD Billion in 2024.

The Traditional Separation Method segment is expected to grow to 16.5 USD Billion by 2035.

Major players in the US Chiral Chemicals Market include Chiral Technologies, Lonza Group, Merck, and BASF.

The Biological Separation Method is expected to be valued at 4.8 USD Billion in 2024.

There are significant opportunities for growth driven by advancements in chiral technologies and increasing demand in pharmaceuticals.

Challenges include regulatory hurdles and the high cost of chiral chemicals production.

The overall growth trend in the US Chiral Chemicals Market may be influenced by supply chain dynamics and geopolitical factors.

Leading companies partner with us for data-driven Insights.

clients

Kindly complete the form below to receive a free sample of this Report

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

report-img
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.